New tetracyclic antidepressants

Drugs of Today

Volumn 33, Issue 2, 1997, Pages 95-102

  Sperling, W ^a   Demling, J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; ORG 4428; TECIPTILINE; TETRACYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ANXIETY NEUROSIS; ARTICLE; BRADYCARDIA; COMPULSION; DELIRIUM; DEPRESSION; DROWSINESS; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; HUMAN; LEUKOPENIA; RASH; SCHIZOPHRENIA; SEIZURE;

EID: 0030954275     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hollister, L.E. New psychotherapeutic drugs. J Clin Psychopharmacol 1994, 14(1): 50-63.
2. Steinmeier, E.M., Vorbach, E.U., Arnoldt, K.H. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups. Pharmacopsychiatry 1993, 26(6): 246-53.
3. Gauchard, J.P., Dick, P., Kohler, M. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners. Clin Neuropharmacol 1994, 17(Suppl.): 29-37.
4. Moeller, H.J., Riehl, T., Dietzfelbinger, T. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression. Int Clin Psychopharmacol 1991, 6(3): 179-92.
5. Kontsevoi, V.A., Kolibash, E. Comparative study of age-related effectiveness of tri-and tetracyclic antidepressants. Zh Nevropatol Psikhiatr 1991, 91(9): 58-65.
6. Fuchs, A., Hehnke, U., Erhart, C. Video rating analysis of effect of maprotiline in patients with dementia and depression. Pharmacopsychiatry 1993, 26(2): 37-41.
7. Rouillon, F., Serrurier, D., Miller, H.D., Gerard, M.J. Prophylactic efficacy of maprotiline on unipolar depression relapse. J Clin Psychiatry 1991, 52: 423-31.
8. Melzer, H. (Ed.). Psychopharmacology. Raven Press: New York 1987.
9. Koenig, F., Stumpp, W. Follow-up of Werlhof disease after onset of treatment with maprotiline. Nervenarzt 1995, 66(1): 60-5.
10. Zogno, M.G., Tolfo, L. Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics. Ann Pharmacother 1994, 28(3): 406.
11. Kiyatake, I., Yamaji, K., Shirato, I. A case of neuroleptic malignant syndrome with acute renal failure after the discontinuation of sulpiride and maprotiline. Jpn J Med 1991, 30(4): 387-91.
12. Niederauer, H.H., Bacharach Buhles, M.., Altmeyer, P. Ichthyosis and alopecia after maprotiline: Corneolysis caused by temporary disorder of keratinization. Hautarzt 1991, 42(7): 455-8.
13. Whiteford, H.A., Jarvais, M.R. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo. Life Sci 1993, 53(4): 371.
14. Tang, S.W., Seeman, P. Effect of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn-Schmied Arch Pharmacol 1984, 311: 255-61.
15. Mishra, R., Janovsky, A., Sulser, F. Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding. Neuropsychopharmacology 1980, 19: 983-7.
16. Moon, C.A., Jesinger, D.K. The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice. Br J Clin Pract 1991, 45: 259-62.
17. Lauritzen, L., Bendsen, B.B., Vilmar, T. Post stroke depression: Combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology 1994, 114(1): 119-22.
18. Dormann, T. Sleep and paroxetine: A comparison with mianserin in elderly depressed patients. Int Clin Psychopharmacol 1992, 6(Suppl. 4): 53-8.
19. Tudor, S. Comparative study of the treatment with tetracyclic and tricyclic antidepressants in patients with minor depressive disorders. Rom J Neurol Psychiatry 1994, 32(4): 185-98.
20. Mizuki, Y., Kajimura, N., Kai, S. Effects of mianserin in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1992, 16(4): 517-28.
21. Bonne, O., Shalev, A.Y., Bloch, M. Delirium associated with mianserin. Eur Neuropsychopharmacol 1995, 5(2): 147-9.
22. Poyuvovski, M., Meerovich, I., Weizman, A. Beneficial effect of low-dose mianserin on fluvoxamine induced akathisia in an obsessive-compulsive patient. Int Clin Psychopharmacol 1995, 10(2): 11-4.
23. Carcone, B., Vial, T., Chaillet, N., Descotes, J. Symptomatic bradycardia caused by mianserin at therapeutic doses. Hum Exp Toxicol 1991, 10(5): 383-4.
24. Garcia, J.C. Mianserinagranulocytosis followed by oxitriptan eosinophilia. Nervenarzt 1992, 63(5): 303-7.
25. Barbare, J.C., Biour, M., Cardot, T. Hepatotoxicity of mianserin: A case with positive reintroduction. Gastroenterol Clin Biol 1992, 16(5): 486-8.
26. Adams, P.C., Robinson, A., Reid, M.M. Blood dyscrasias and mianserin. Postgrad Med J 1983, 59: 31-3.
27. Coulter, D.M. Mianserin and agranulocytosis. Lancet 1990, ii: 1010.
28. Inman, W.H.W. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet 1988, ii: 90-2.
29. Jick, H. Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone. Pharmacotherapy 1992, 12(6): 451-4.
30. Demling, J. Tetracyclische Antidepressiva. Nervenheilkunde 1996, 15: 92-100.
31. Van Moffaert, M., De Wilde, J. Mirtazapine is more effective than trazodone: A double blind controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol 1995, 10: 3-9.
32. De Boer, T.H., Nefkens, F., Van Helvoirt, A. Differences in modulation of noradrenergic and serotonergic transmission by the α-2 adrenoreceptor antagonists, mirtazapine, mianserin and idazoxan. J Pharmacol Exp Ther 1996, 277: 852-60.
33. Bremner, J.D. A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. J Clin Psychiatry 1995, 56: 519-25.
34. Smith, W.T., Glaudin, V. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacol Bull 1990, 26: 191-6.
35. Zivkov, M., DeJongh, G.D. Org 3770 versus amitriptyline: A 6-week randomized double-blind multicenter trial in hospitalized depressed patients. Hum Psychopharmacol Clin Exp 1995, 10: 173-80.
36. Marttila, M., Jaaskelainen, J., Jarvi, R. A double blind study comparing the efficacy and tolerability of Org 3770 and doxepin in patients with major depression. Eur J Neuropsychopharmacol 1995, 5: 441-6.
37. Sitsen, J.M.A., Moors, J. Mirtazapine, a novel antidepressant, in the treatment of anxiety symptoms. Results from a placebo-controlled trial. Drug Invest 1994, 8: 339-44.
38. Kamimura, M., Aoba, A. The effect of age on plasma level of setiptiline maleate in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 1994, 18: 1015-26.
39. Kuniyoshi, M., Nakamura, J., Miura, C. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994, 18: 339-46.
40. Ruigt, G.S.F., Kemp, B., Groenhout, C.M. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990, 38: 551-4.